Jsr Realbuild Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 03-07-2024
- Paid Up Capital ₹ 1.50 M
as on 03-07-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit 27.92%
(FY 2020)
- Ebitda -41.65%
(FY 2020)
- Net Worth -129.79%
(FY 2020)
- Total Assets -48.61%
(FY 2020)
About Jsr Realbuild
The Corporate was formerly known as Jsr Tour & Travels Private Limited. The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Fatehjeet Singh, Jorawar Rathore, Amrik Singh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U70100DL2012PTC234543
- Company No.
234543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Jsr Realbuild?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amrik Singh  | Director | 19-Apr-2012 | Current |
| Fatehjeet Singh | Director | 23-Feb-2013 | Current |
| Jorawar Rathore | Director | 19-Apr-2012 | Current |
| Gurmeet Singh | Director | 12-Oct-2021 | Current |
| Jasveer Singh | Director | 23-Feb-2013 | Current |
Financial Performance of Jsr Realbuild.
Jsr Realbuild Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 27.92% increase in profit. The company's net worth observed a substantial decline by a decrease of 129.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jsr Realbuild?
In 2019, Jsr Realbuild had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sat Akal Remedies Private LimitedActive 11 years 2 monthsJorawar Rathore, Amrik Singh and 1 more are mutual person
Well-Era Medical Supplies LlpActive 4 years 5 monthsJorawar Rathore, Amrik Singh and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jsr Realbuild?
Unlock and access historical data on people associated with Jsr Realbuild, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jsr Realbuild, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jsr Realbuild's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
